Boosting immune cells could provide TB treatment
A new study has identified a class of immune cells that respond to tuberculosis, indicating a drug target for the condition.
List view / Grid view
A new study has identified a class of immune cells that respond to tuberculosis, indicating a drug target for the condition.
Researchers have found that certain immune cells aid in fighting tuberculosis bacteria, providing a new drug target.
28 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Tuberculosis is the most deadly infectious disease in the world. Standard TB therapy takes at least 6 months and patients infected with multi-drug...